Jihong Liu

4PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 11, 2025
Comprehensive Multiomics Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.

Ting Wan, Ting Deng, Xinxin Peng

|Jun 14, 2024
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.

Xiaohua Wu, Jihong Liu, Ruifang An

|Apr 12, 2024
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).

Yusuke Kobayashi, Muneaki Shimada, Masato Tamate

|Apr 11, 2022
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial.

Ning Li, Youzhong Zhang, Jing Wang

Pageof 1

Frequent Collaborators

2 joint publications

Jianqing Zhu

2 joint publications

Rutie Yin

1 joint publications

Xiaohua Wu

1 joint publications

Yi Huang